Mentor/s
Dr Christina Gunther
Participation Type
Paper Talk
Abstract
Continuing medical education (CME) is an essential component of ongoing professional development for healthcare providers. However, the pharmaceutical industry’s influence on CME has raised concerns about potential conflicts of interest and biased education. Big Pharma’s funding, sponsorship, and marketing practices have significant implications for the content and direction of CME, potentially leading to healthcare providers receiving biased information and prescribing drugs based on commercial interests rather than patient needs. This paper will examine the ways in which the pharmaceutical industry influences CME and the potential consequences of this influence, as well as the measures that medical associations, universities, and healthcare providers can take to ensure that CME remains unbiased and evidence based. More specifically, it will focus on the mis actions of the American Medical Association, in particular the streams of revenue feeding the organization, and analyze a case study on the OxyContin Crisis to guide readers towards the conclusion that the governing bodies around CME are allowing for outside pharmaceutical companies to manipulate the material being taught to practitioners.
College and Major available
College of Health Professions, Health Science
Location
Session 15: Digital Commons & West Campus West Building Room 213
Start Day/Time
4-28-2023 9:00 AM
End Day/Time
4-28-2023 10:15 AM
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
Prize Categories
Best Multidisciplinary Research or Collaboration, Most Scholarly Impact or Potential, Most Creative
Follow The Money- Investigating the Influence of Pharmaceutical Companies on Continuing Medical Education
Session 15: Digital Commons & West Campus West Building Room 213
Continuing medical education (CME) is an essential component of ongoing professional development for healthcare providers. However, the pharmaceutical industry’s influence on CME has raised concerns about potential conflicts of interest and biased education. Big Pharma’s funding, sponsorship, and marketing practices have significant implications for the content and direction of CME, potentially leading to healthcare providers receiving biased information and prescribing drugs based on commercial interests rather than patient needs. This paper will examine the ways in which the pharmaceutical industry influences CME and the potential consequences of this influence, as well as the measures that medical associations, universities, and healthcare providers can take to ensure that CME remains unbiased and evidence based. More specifically, it will focus on the mis actions of the American Medical Association, in particular the streams of revenue feeding the organization, and analyze a case study on the OxyContin Crisis to guide readers towards the conclusion that the governing bodies around CME are allowing for outside pharmaceutical companies to manipulate the material being taught to practitioners.
Students' Information
Jayden Tabor, Honor's Program Health Science Senior with a concentration in Healthcare Administration and a minor in Women, Gender, and Sexuality Studies (Graduating 2023)